在群众中:多个左前庭未分化形肉瘤
Kevin Yager1, Jerry Fan2, Corry B Sanford1
1Department of Internal Medicine, Baylor Scott & White Medical Center, Temple, TX.
Ochsner journal
|December 25, 2024
概括
不分化形肉瘤是一种罕见的,侵略性的心脏瘤. 及时诊断和治疗,包括手术和化疗,可以带来长期的稳定性和改善患者的结果.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 不差异化的多形肉瘤 (UPS) 是一种具有不良预后的侵袭性初级心脏瘤.
- UPS源于介质干细胞,并与高死亡率有关.
- 此前在该患者身上发现了严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 心肌炎和缺铁性贫血.
研究的目的:
- 报告一种罕见的未分化形肉瘤病例,呈现为左心房质量.
- 突出诊断挑战和初级心脏肉瘤的成功管理.
- 强调及时诊断和多模式治疗心脏瘤的重要性.
主要方法:
- 一名52岁的女性出现了心痛和呼吸障碍的症状.
- 诊断工作包括提升的热素1,D-二次体,心声学和正子发射断层扫描 (PET) 扫描.
- 进行了左心房质量的手术切除,随后进行了化疗.
主要成果:
- 病理学证实了左心房的高度不分化形肉瘤.
- 患者在治疗后9个月实现了临床稳定,没有放射性复发.
- 长期随访 (>2年) 显示心脏功能正常,肺高血压消失.
结论:
- 由于位置和活检的困难,左心房质量带来了诊断挑战.
- 及时诊断和治疗不分化形肉瘤对于改善生存率至关重要.
- 这一案例证明了初级心脏肉瘤的及时干预可能带来有利结果的潜力.
更多相关视频
09:21Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
7.1K
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
1.1K
相关概念视频
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
